The Vasodilatory Response to CGRP of the Anterior and Posterior Cerebral Circulation in Migraine

被引:3
作者
Visocnik, Darja [1 ]
Zaletel, Marjan [1 ]
Zvan, Bojana [1 ]
Zupan, Matija [1 ]
机构
[1] Univ Med Ctr Ljubljana, Dept Neurol, Ljubljana, Slovenia
来源
FRONTIERS IN NEUROLOGY | 2022年 / 13卷
关键词
migraine; aura; headache; CGRP; vasodilatory response; SPREADING DEPRESSION; AURA; REACTIVITY; PATHOPHYSIOLOGY;
D O I
10.3389/fneur.2022.854134
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IntroductionMigraine aura can be associated with headache or it may occur without one, which suggests an independent mechanism for the aura and for migraine headache. The role of CGRP in migraine headache is well established, but the connection between CGRP and the aura is still lacking an explanation. Exogenous CGRP can induce CGRP headaches and migraine auras in patients with migraine. The results of our recent study suggest differences in the vascular response to CGRP stimulation between migraine without aura and migraine with aura. Therefore, we hypothesized that the magnitude of the posterior cerebral circulation response in migraine with aura is greater than in migraine without aura and that CGRP stimulation has different effects on the anterior and posterior circulation in migraine with aura and migraine without aura. MethodsBy using transcranial doppler, we studied the hemodynamic effects of CGRP intravenous infusion at a rate of 1.5 mcg/min in 20 min on the mean arterial velocity in the middle cerebral artery and in the posterior cerebral artery in twenty patients with migraine and in a control group of twenty healthy subjects. The same CGRP effects on cerebral hemodynamics were analyzed separately for the group of patients with migraine with aura and the group of patients with migraine without aura. Fifteen patients with migraine (75%) had migraine without aura and 5 patients (25%) had migraine with aura. ResultsWe found that migraine has a significant impact on the vasodilatory response of the anterior (B = 4,249, SE = 1.023, r = 0.363, p < 0.001) and posterior cerebral circulation (B = 3.634, SE = 1.461, r = 0.227, p = 0.014). Migraine with aura was significantly associated with changes in the anterior (B = 2.558, SE = 0.880, r = 0.275, p = 0.005) and posterior cerebral circulation (B = 7.565, SE = 2,368, r = 0.359, p = 0.002), while migraine without aura was only significantly associated with changes in the anterior circulation. In addition, we established a significant impact of migraine with aura on VR PCA (B = 5.901, SE = 2,546, r = 0.291, p = 0.024). ConclusionWe conclude that TVR in the posterior cerebral circulation might be enhanced in MA and that aura might be a consequence of TVR enhancement.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Predicting response to CGRP-monoclonal antibodies in patients with migraine in Japan: a single-centre retrospective observational study
    Ihara, Keiko
    Ohtani, Seiya
    Watanabe, Narumi
    Takahashi, Nobuyuki
    Miyazaki, Naoki
    Ishizuchi, Kei
    Hori, Satoko
    Takemura, Ryo
    Nakahara, Jin
    Takizawa, Tsubasa
    [J]. JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01)
  • [22] Predicting response to CGRP-monoclonal antibodies in patients with migraine in Japan: a single-centre retrospective observational study
    Keiko Ihara
    Seiya Ohtani
    Narumi Watanabe
    Nobuyuki Takahashi
    Naoki Miyazaki
    Kei Ishizuchi
    Satoko Hori
    Ryo Takemura
    Jin Nakahara
    Tsubasa Takizawa
    [J]. The Journal of Headache and Pain, 24
  • [23] Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries:: potential implications in acute migraine treatment
    Moreno, MJ
    Abounader, R
    Hébert, E
    Doods, H
    Hamel, E
    [J]. NEUROPHARMACOLOGY, 2002, 42 (04) : 568 - 576
  • [24] Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients
    Barbanti, Piero
    Egeo, Gabriella
    Aurilia, Cinzia
    Altamura, Claudia
    D'Onofrio, Florindo
    Finocchi, Cinzia
    Albanese, Maria
    Aguggia, Marco
    Rao, Renata
    Zucco, Maurizio
    Frediani, Fabio
    Filippi, Massimo
    Messina, Roberta
    Cevoli, Sabina
    Carnevale, Antonio
    Fiorentini, Giulia
    Messina, Stefano
    Bono, Francesco
    Torelli, Paola
    Proietti, Stefania
    Bonassi, Stefano
    Vernieri, Fabrizio
    [J]. JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01)
  • [25] Average steps per day as marker of treatment response with anti-CGRP mAbs in adults with chronic migraine: a pilot study
    Jantzen, Frederik Thal
    Chaudhry, Basit Ali
    Younis, Samaira
    Norgaard, Ina
    Cullum, Christopher Kjaer
    Do, Thien Phu
    Beier, Dagmar
    Amin, Faisal Mohammad
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [26] An evolving machine-learning-based algorithm to early predict response to anti-CGRP monoclonal antibodies in patients with migraine
    Romozzi, Marina
    Lokhandwala, Ammar
    Vollono, Catello
    Vigani, Giulia
    Burgalassi, Andrea
    Garcia-Azorin, David
    Calabresi, Paolo
    Chiarugi, Alberto
    Geppetti, Pierangelo
    Iannone, Luigi Francesco
    [J]. CEPHALALGIA, 2024, 44 (12)
  • [27] Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study
    Kruit, MC
    Launer, LJ
    Ferrari, MD
    van Buchem, MA
    [J]. BRAIN, 2005, 128 : 2068 - 2077
  • [28] Potential Predictors of Response to CGRP Monoclonal Antibodies in Chronic Migraine: Real-World Data
    Sanchez-Rodriguez, Carmen
    Gago-Veiga, Ana Beatriz
    Garcia-Azorin, David
    Guerrero-Peral, Angel Luis
    Gonzalez-Martinez, Alicia
    [J]. CURRENT PAIN AND HEADACHE REPORTS, 2024, 28 (12) : 1265 - 1272
  • [29] Site-specific different dynamic cerebral autoregulation and cerebrovascular response to carbon dioxide in posterior cerebral circulation during isometric exercise in healthy young men
    Washio, Takuro
    Watanabe, Hironori
    Suzuki, Kazuya
    Saito, Shotaro
    Ogoh, Shigehiko
    [J]. AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2022, 238
  • [30] Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months
    Caronna, Edoardo
    Jose Gallardo, Victor
    Alpuente, Alicia
    Torres-Ferrus, Marta
    Pozo-Rosich, Patricia
    [J]. JOURNAL OF HEADACHE AND PAIN, 2021, 22 (01)